Cell-type-specific gene delivery into neuronal cells in vitro and in vivo

被引:12
作者
Parveen, Z
Mukhtar, M
Rafi, M
Wenger, DA
Siddiqui, KM
Siler, CA
Dietzschold, B
Pomerantz, RJ
Schnell, MJ
Dornburg, R
机构
[1] Thomas Jefferson Univ, Ctr Human Virol & Biodef, Dorrance H Hamilton Labs, Div Infect Dis, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Microbiol, Philadelphia, PA 19107 USA
[6] Temple Univ, Ctr Neurovirol & Canc Biol, Philadelphia, PA 19122 USA
关键词
retroviral vectors; reticuloendotheliosis viruses; SNV; neurons; gene therapy; rabies virus;
D O I
10.1016/S0042-6822(03)00402-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The avian retroviruses reticuloendotheliosis virus strain A (REV-A) and spleen necrosis virus (SNV) are not naturally infectious in human cells. However, REV-A-derived viral vectors efficiently infect human cells when they are pseudotyped with envelope proteins displaying targeting ligands specific for human cell-surface receptors. Here we report that vectors containing the gag region of REV-A and pol of SNV can be pseudotyped with the envelope protein of vesicular stomatitis virus (VSV) and the glycoproteins of different rabies virus (RV) strains. Vectors pseudotyped with the envelope protein of the highly neurotropic RV strain CVS-N2c facilitated cell type-specific gene delivery into mouse and human neurons, but did not infect other human cell types. Moreover, when such vector particles were injected into the brain of newborn mice, only neuronal cells were infected in vivo. Cell-type-specific gene delivery into neurons may present quite specific gene therapy approaches for many degenerative diseases of the brain. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 46 条
[41]  
Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO
[42]  
2-9
[43]  
Roy NS, 2000, NAT MED, V6, P271
[44]   Gene therapy using viral vectors for acute neurologic insults [J].
Sapolsky, RM ;
Steinberg, GK .
NEUROLOGY, 1999, 53 (09) :1922-1931
[45]   Gene therapy in the central nervous system - The use of recombinant retroviruses [J].
Suhr, ST ;
Gage, FH .
ARCHIVES OF NEUROLOGY, 1999, 56 (03) :287-292
[46]   THE NUCLEAR-LOCALIZATION SIGNAL OF THE MATRIX PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ALLOWS THE ESTABLISHMENT OF INFECTION IN MACROPHAGES AND QUIESCENT T-LYMPHOCYTES [J].
VONSCHWEDLER, U ;
KORNBLUTH, RS ;
TRONO, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :6992-6996